Clinical Trial Update: Biomarkers in Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 biomarker study in schizophrenia and schizoaffective disorder; the trial has completed and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: Nathan Kline Institute for Psychiatric Research | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 2 | Status: COMPLETED | Results posted: 2017-08-02